Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Amanda Hanson"'
Autor:
Glenn S. Gerhard, Bethany Davis, Xiumei Wu, Amanda Hanson, Danielle Wilhelmsen, Ignazio S. Piras, Christopher D. Still, Xin Chu, Anthony T. Petrick, Johanna K. DiStefano
Publikováno v:
Biochemistry and Biophysics Reports, Vol 22, Iss , Pp - (2020)
We previously reported dysregulated expression of liver-derived messenger RNA (mRNA) and long noncoding RNA (lncRNA) in patients with advanced fibrosis resulting from nonalcoholic fatty liver disease (NAFLD). Here we sought to identify changes in mRN
Externí odkaz:
https://doaj.org/article/d90250de239646099a9ee0ad54099ab8
Autor:
Amanda Hanson, Kutlu Elpek, Ellen Duong, Lindsey Shallberg, Martin Fan, Calvin Johnson, Matthew Wallace, George R Mabry, Stephen Sazinsky, Lauren Pepper, Chengyi J Shu, Sriram Sathyanarayanan, Sarah Zuerndorfer, Tyler Simpson, Monica Gostissa, Michael Briskin, Deborah Law, Jennifer Michaelson, Christopher J Harvey
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0239595 (2020)
Immunotherapy checkpoint inhibitors, such as antibodies targeting PD-1 and CTLA-4, have demonstrated the potential of harnessing the immune system to treat cancer. However, despite encouraging results particularly with respect to survival, only a min
Externí odkaz:
https://doaj.org/article/12342d258a3a4c9696b7dad685961d58
Autor:
Glenn S Gerhard, Amanda Hanson, Danielle Wilhelmsen, Ignazio S Piras, Christopher D Still, Xin Chu, Anthony T Petrick, Johanna K DiStefano
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219764 (2019)
Factors governing the development of liver fibrosis in nonalcoholic steatohepatitis (NASH) are only partially understood. We recently identified adipocyte enhancer binding protein 1 (AEBP1) as a member of a core set of dysregulated fibrosis-specific
Externí odkaz:
https://doaj.org/article/7d9a7df140ee4a8eb0ebdc0803ef121f
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0166280 (2016)
T lymphocytes require signals from self-peptides and cytokines, most notably interleukins 7 and 15 (IL-7, IL-15), for survival. While mouse T cells die rapidly if IL-7 or IL-15 is withdrawn, human T cells can survive prolonged withdrawal of IL-7 and
Externí odkaz:
https://doaj.org/article/a00c3a4cf52044a5a59471547dbd31d0
Publikováno v:
Non-Coding RNA, Vol 4, Iss 3, p 18 (2018)
Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of conditions ranging from hepatic steatosis to inflammation (nonalcoholic steatohepatitis or NASH) with or without fibrosis, in the absence of significant alcohol consumption. The prese
Externí odkaz:
https://doaj.org/article/3fd4dd26375e447eab647e2ef863b12e
Autor:
Christopher J. Harvey, Elizabeth Trehu, Richard Murray, Haley Laken, Johan Baeck, Weidong Zhang, Judith Jimenez, Ali Sepahi, Karen Brown, Rachel McComb, Courtney Hart, Daniel Felitsky, Martin Fan, Heather Cohen, Xiaoying Xiao, Ellen Hooper, Lara McGrath, Yasmin Hashambhoy-Ramsay, Amanda Hanson, Haeseong Park, Mariela Blum Murphy, Kyriakos P. Papadopoulos, Tanguy Y. Seiwert, Osama E. Rahma, Scott S. Tykodi, Howard A. Burris, Geoffrey T. Gibney, Shivaani Kummar, Patricia LoRusso, Russell K. Pachynski, Gerald S. Falchook, Margaret K. Callahan, Justin F. Gainor, Timothy A. Yap
Supplementary Data from First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04ebbd64661cbba269a9c3230a5032f2
https://doi.org/10.1158/1078-0432.22487579.v1
https://doi.org/10.1158/1078-0432.22487579.v1
Autor:
Christopher J. Harvey, Elizabeth Trehu, Richard Murray, Haley Laken, Johan Baeck, Weidong Zhang, Judith Jimenez, Ali Sepahi, Karen Brown, Rachel McComb, Courtney Hart, Daniel Felitsky, Martin Fan, Heather Cohen, Xiaoying Xiao, Ellen Hooper, Lara McGrath, Yasmin Hashambhoy-Ramsay, Amanda Hanson, Haeseong Park, Mariela Blum Murphy, Kyriakos P. Papadopoulos, Tanguy Y. Seiwert, Osama E. Rahma, Scott S. Tykodi, Howard A. Burris, Geoffrey T. Gibney, Shivaani Kummar, Patricia LoRusso, Russell K. Pachynski, Gerald S. Falchook, Margaret K. Callahan, Justin F. Gainor, Timothy A. Yap
Purpose:The first-in-human phase I/II ICONIC trial evaluated an investigational inducible costimulator (ICOS) agonist, vopratelimab, alone and in combination with nivolumab in patients with advanced solid tumors.Patients and Methods:In phase I, patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a19542e01becf31c2cae0af3d383c04
https://doi.org/10.1158/1078-0432.c.6532550
https://doi.org/10.1158/1078-0432.c.6532550
Autor:
Elizabeth Koch, Amy Berkley, Sean Phippen, Max London, Kerry White, Amanda Hanson, Sam Cooper, Christopher Harvey, Michael Briskin
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f10e51b89bc5395a03e19686497b0075
https://doi.org/10.1136/jitc-2022-sitc2022.1350
https://doi.org/10.1136/jitc-2022-sitc2022.1350
Autor:
Timothy A. Yap, Justin F. Gainor, Margaret K. Callahan, Gerald S. Falchook, Russell K. Pachynski, Patricia LoRusso, Shivaani Kummar, Geoffrey T. Gibney, Howard A. Burris, Scott S. Tykodi, Osama E. Rahma, Tanguy Y. Seiwert, Kyriakos P. Papadopoulos, Mariela Blum Murphy, Haeseong Park, Amanda Hanson, Yasmin Hashambhoy-Ramsay, Lara McGrath, Ellen Hooper, Xiaoying Xiao, Heather Cohen, Martin Fan, Daniel Felitsky, Courtney Hart, Rachel McComb, Karen Brown, Ali Sepahi, Judith Jimenez, Weidong Zhang, Johan Baeck, Haley Laken, Richard Murray, Elizabeth Trehu, Christopher J. Harvey
Publikováno v:
Clin Cancer Res
Purpose: The first-in-human phase I/II ICONIC trial evaluated an investigational inducible costimulator (ICOS) agonist, vopratelimab, alone and in combination with nivolumab in patients with advanced solid tumors. Patients and Methods: In phase I, pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ed38ce215255493942ef71d231ae66c
https://pubmed.ncbi.nlm.nih.gov/35792807
https://pubmed.ncbi.nlm.nih.gov/35792807
Publikováno v:
Lecture Notes in Civil Engineering ISBN: 9783030772338
Geotrack™ is a software for railroad track and subgrade analysis originally developed in the 1980s and is owned by Transportation Technology Center, Inc. (TTCI), a subsidiary of the Association of American Railroads (AAR). Geotrack™ provides vali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d236eb1ba2a44031c726ac3c1f0cfaf
https://doi.org/10.1007/978-3-030-77234-5_26
https://doi.org/10.1007/978-3-030-77234-5_26